Ripple unlocked 1 billion XRP tokens valued at $1.63 billion as part of its monthly funding strategy, with 300 million tokens now reserved for February operationsRipple unlocked 1 billion XRP tokens valued at $1.63 billion as part of its monthly funding strategy, with 300 million tokens now reserved for February operations

Ripple Unlocks 1 Billion XRP Worth $1.63 Billion: Will Price Recover?

3 min read

Ripple unlocked 1 billion XRP XRP $1.63 24h volatility: 1.5% Market cap: $99.32 B Vol. 24h: $5.61 B —worth approximately $1.63 billion—on February 2, as part of its funding strategy. 300 million XRP—worth half a billion dollars—are now reserved at its main treasury account, reserved for the company’s sales this month. Coinspeaker researched this information via publicly available, on-chain data retrieved from Ripple-owned accounts, labeled by XRPScan.

Notably, the funds come from previously locked XRP tokens via escrows created in 2022 that date back to XRP’s pre-mint and initial distribution. February 2026’s unlocks happened from the accounts labeled as Ripple (9) and Ripple (28), with four escrows reaching finality on Feb. 1.

Each account unlocked 500 million XRP in total, out of which came from escrows of 100 million and 400 million XRP tokens. These were then reallocated to three other accounts, following a pattern observed in previous months.

The Ripple (28) account sent 100 million XRP to Ripple (14) and 400 million XRP to Ripple (15), which have been re-locked in new escrows set to finish (and unlock) in December 2026. Meanwhile, the Ripple (9) account sent 200 million XRP to Ripple (14) for the same reason, plus 300 million tokens to Ripple (1), identified as the company’s liquid treasury account—used for funds distribution operations like OTC sales and exchange deposits.

Ripple on-chain data flow | Monthly Escrow Unlock February 2026 | Source: Coinspeaker / XRPScan

Ripple on-chain data flow | Monthly Escrow Unlock February 2026 | Source: Coinspeaker / XRPScan

XRP Price Analysis

As of this writing, XRP is trading at $1.63 per token, with accumulated losses of 18% in the past 30 days, following macro uncertainty and a trend also seen in most of the other cryptocurrencies. For example, crypto products recorded a net outflow of $1.7 billion in the last week alone, affecting the supply side of their underlying assets in open markets.

According to data from CoinMarketCap, XRP has a market capitalization of nearly $100 billion, positioned as the fifth-largest crypto by market cap. With a currently circulating supply of 60 billion XRP, the recent unlock represents 1.66% of that amount and the 300 million reserved for February operations represents 0.5% of that active supply.

XRP price (30D chart) as of Feb. 2, 2026 | Source: CoinMarketCap

XRP price (30D chart) as of Feb. 2, 2026 | Source: CoinMarketCap

On the other hand, Ripple, the company behind XRP’s issuance, unlocks, and ongoing developments, continues to push and advance in many areas, with a highlight to compliance-related movements. In the most recent development, Ripple has been granted a full Electronic Money Institution (EMI) license by Luxembourg’s CSSF, as Coinspeaker reported.

next

The post Ripple Unlocks 1 Billion XRP Worth $1.63 Billion: Will Price Recover? appeared first on Coinspeaker.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29